The ABCs of SLEEPING for Sleep disorders and disturbances

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Sleep disorders and disturbances+4 More
The ABCs of SLEEPING - Behavioral
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial will examine the effectiveness of a mobile applicable intervention called the "ABCs of SLEEPING". This intervention provides parents with prioritized/customized sleep recommendations and a sleep report based on their responses to the "Sleep check-in".

Eligible Conditions
  • Sleep disorders and disturbances
  • Sleeplessness

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Sleep disorders and disturbances

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Measured for 5-7 days at pre-test, and 5-7 days at post-test (i.e., 6-week follow up) to examine change in sleep efficiency (i.e., objective measures of sleep).

Day 7
Actigraphy (i.e., sleep efficiency measure).
Day 7
Actigraphy (i.e., sleep onset latency measure).
Day 7
Sleep Diary
Measured once at pre-test and once at post-test (i.e., 6-week follow up) to examine change in pediatric insomnia severity.
Pediatric Insomnia Severity Index (i.e., pediatric insomnia severity measure)
Measured once at pre-test and once at post-test (i.e., 6-week follow up) to examine change in sleep habits.
Children's Sleep Habits Questionnaire (i.e., child sleep habits measure)

Trial Safety

Safety Progress

1 of 3

Other trials for Sleep disorders and disturbances

Trial Design

2 Treatment Groups

Control group
1 of 2
Intervention
1 of 2
Active Control
Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: The ABCs of SLEEPING · No Placebo Group · N/A

Intervention
Behavioral
Experimental Group · 1 Intervention: The ABCs of SLEEPING · Intervention Types: Behavioral
Control groupNoIntervention Group · 1 Intervention: Control group · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: measured for 5-7 days at pre-test, and 5-7 days at post-test (i.e., 6-week follow up) to examine change in sleep efficiency (i.e., objective measures of sleep).

Who is running the clinical trial?

IWK Health CentreLead Sponsor
117 Previous Clinical Trials
97,100 Total Patients Enrolled
1 Trials studying Sleep disorders and disturbances
61 Patients Enrolled for Sleep disorders and disturbances
Penny Corkum, PhDPrincipal InvestigatorIWK Health Centre; Dalhousie University
1 Previous Clinical Trials
218 Total Patients Enrolled

Eligibility Criteria

Age < 18 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 6th, 2021

Last Reviewed: October 19th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.